Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
BSE: 526504 | NSE: | Hospital & Healthcare Services | Small Cap
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Dolphin Medical Services Ltd is a below average quality company.
The key valuation ratios of Dolphin Medical Services Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Dolphin Medical Services Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -3.8% | -2.6% | -0% | -1% | -1.4% | -2.7% | -2.2% | 25.2% | -1.6% | -1.1% | - |
| Value Creation Index ⓘ | -1.3 | -1.2 | -1.0 | -1.1 | -1.1 | -1.2 | -1.2 | 0.8 | -1.1 | -1.1 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 1 | 0.4 | 0.6 | 0.4 | 0.2 | 0.1 | 0.2 | 0.5 | 0.5 | 0.6 | 1 |
| Sales YoY Gr. | - | -62.5% | 58.3% | -38.6% | -57.1% | -60% | 200% | 161.1% | 10.6% | 17.3% | - |
| Adj EPS ⓘ | -0.6 | -0.4 | -0 | -0.1 | -0.2 | -0.3 | -0.3 | 2.4 | -0.1 | -0.1 | -0 |
| YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | -105.1% | NA | - |
| BVPS (₹) ⓘ | 8.9 | 8.5 | 8.5 | 8.3 | 8.1 | 7.4 | 7.2 | 7 | 6.8 | 6.7 | 6.8 |
| Adj Net Profit ⓘ | -0.9 | -0.6 | -0.1 | -0.2 | -0.3 | -0.5 | -0.4 | 3.6 | -0.2 | -0.1 | 0 |
| Cash Flow from Ops. ⓘ | 0.2 | 0.1 | -0.1 | -0.1 | 0 | 0 | -0.1 | 0.3 | -0.1 | -0.1 | - |
| Debt/CF from Ops. ⓘ | 43.8 | 176 | -67 | -114 | -2600.6 | 335.4 | -47.7 | 2.2 | -6.9 | -10.9 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -4.9% | 32.4% | 50.2% | 17.3% | ||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||
| BVPSⓘ | -3% | -3.5% | -2% | -1.2% | ||||
| Share Price | 7.7% | 11.4% | 10.6% | 45.6% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -6.3 | -4.4 | -0.4 | -1.6 | -2.4 | -4.4 | -3.5 | 33.3 | -1.8 | -1.2 | -0.6 |
| Op. Profit Mgn % ⓘ | -9.8 | -10.7 | 30.5 | 5.2 | -52.8 | -229.3 | -188.1 | -54.7 | -26.8 | -13.3 | -5.7 |
| Net Profit Mgn % ⓘ | -90.2 | -158 | -8.2 | -58.7 | -194.5 | -864.8 | -211.4 | 749.9 | -36 | -20.4 | -9.7 |
| Debt to Equity ⓘ | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.6 | 0.1 | 0.1 | 0.1 | - |
| Working Cap Days ⓘ | 1,783 | 4,498 | 2,961 | 5,066 | 11,848 | 29,872 | 9,661 | 3,697 | 3,358 | 2,856 | 785 |
| Cash Conv. Cycle ⓘ | 12 | 12 | 0 | 6 | 9 | 11 | 0 | 1 | 1 | 2 | 528 |
Sales growth is growing at healthy rate in last 3 years 50.21%
Return on Equity is Poor
Sales growth is not so good in last 4 quarters at -4.15%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | -0 | -0 |
| TTM Sales (₹ Cr.) | 0.6 | 0.6 |
| BVPS (₹.) ⓘ | 6.8 | 0 |
| Reserves (₹ Cr.) ⓘ | -5 | -2 |
| P/BV ⓘ | 0.34 | 0.00 |
| PE ⓘ | 0.00 | 0.00 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 1.36 / 3.25 |
| All Time Low / High (₹) | 0.39 / 28.40 |
| Market Cap (₹ Cr.) | 3.5 |
| Equity (₹ Cr.) | 15.1 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 86.1 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.96 | 0.36 | 0.57 | 0.35 | 0.15 | 0.06 | 0.18 | 0.47 | 0.52 | 0.61 |
| Operating Expenses ⓘ | 1.05 | 0.40 | 0.39 | 0.42 | 0.23 | 0.89 | 0.53 | 6.25 | 0.66 | 0.69 |
| Manufacturing Costs | 0.09 | 0.04 | 0.02 | 0.02 | 0.03 | 0.03 | 0.05 | 0.10 | 0.05 | 0.06 |
| Material Costs | 0.30 | 0.10 | 0.17 | 0.08 | 0.04 | 0.02 | 0.02 | 0.04 | 0.07 | 0.09 |
| Employee Cost | 0.13 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.06 | 0.07 | 0.07 |
| Other Costs ⓘ | 0.53 | 0.23 | 0.16 | 0.28 | 0.13 | 0.81 | 0.42 | 6.04 | 0.47 | 0.47 |
| Operating Profit ⓘ | -0.09 | -0.04 | 0.17 | -0.07 | -0.08 | -0.83 | -0.34 | -5.77 | -0.14 | -0.08 |
| Operating Profit Margin (%) | -9.8% | -10.7% | 30.5% | -19.7% | -52.8% | -1,386.0% | -188.0% | -1,220.3% | -26.8% | -13.3% |
| Other Income ⓘ | 0 | 0.01 | 0.15 | 0.11 | 0.09 | 0.06 | 0.05 | 5.55 | 0.04 | 0.04 |
| Interest ⓘ | 0.05 | 0.05 | 0.06 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation ⓘ | 0.71 | 0.52 | 0.34 | 0.33 | 0.33 | 0.24 | 0.06 | 0.06 | 0.06 | 0.06 |
| Exceptional Items ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | -0.86 | -0.59 | -0.07 | -0.30 | -0.33 | -1.03 | -0.36 | -0.30 | -0.18 | -0.12 |
| Tax ⓘ | 0 | -0.02 | -0.02 | -0.03 | -0.04 | -0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Profit After Tax | -0.86 | -0.57 | -0.05 | -0.27 | -0.30 | -1.01 | -0.39 | -0.31 | -0.19 | -0.12 |
| PAT Margin (%) | -90.2% | -158.0% | -8.2% | -76.1% | -194.0% | -1,674.5% | -211.0% | -66.0% | -36.0% | -20.4% |
| Adjusted EPS (₹) | -0.6 | -0.4 | 0.0 | -0.2 | -0.2 | -0.7 | -0.3 | -0.2 | -0.1 | -0.1 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 13.38 | 12.80 | 12.76 | 12.49 | 12.19 | 11.19 | 10.80 | 10.49 | 10.30 | 10.18 |
| Share Capital ⓘ | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 | 15.10 |
| Reserves ⓘ | -1.72 | -2.30 | -2.34 | -2.61 | -2.91 | -3.91 | -4.30 | -4.61 | -4.80 | -4.92 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt | 8.10 | 8.05 | 8.16 | 8.21 | 8.21 | 6.22 | 6.37 | 0.61 | 0.68 | 0.76 |
| Long Term Debt | 8.10 | 8.05 | 8.16 | 8.21 | 8.21 | 6.22 | 6.37 | 0.61 | 0.68 | 0.76 |
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Payables | 0.01 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others Liabilities ⓘ | 0.75 | 0.72 | 0.68 | 0.65 | 0.61 | 0.58 | 0.71 | 1.23 | 1.25 | 1.24 |
| Total Liabilities ⓘ | 22.23 | 21.59 | 21.60 | 21.35 | 21.01 | 17.99 | 17.88 | 12.33 | 12.23 | 12.17 |
Fixed Assets | ||||||||||
| Gross Block | 15.27 | 15.25 | 14.28 | 14.28 | 13.99 | 11.33 | 11.34 | 3.95 | 3.95 | 3.95 |
| Accumulated Depreciation | 4.04 | 4.54 | 3.91 | 4.25 | 4.30 | 4.54 | 4.60 | 0.95 | 1.01 | 1.07 |
| Net Fixed Assetsⓘ | 11.23 | 10.71 | 10.36 | 10.03 | 9.70 | 6.79 | 6.74 | 3 | 2.94 | 2.87 |
| CWIP ⓘ | 5.93 | 5.93 | 5.93 | 5.93 | 5.93 | 5.93 | 5.93 | 4.09 | 4.09 | 4.09 |
| Investmentsⓘ | 0.52 | 0.52 | 0.52 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| Inventories | 0.03 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Equivalents | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0.04 | 0.01 | 0.01 |
| Others Assetsⓘ | 4.51 | 4.41 | 4.77 | 4.97 | 4.96 | 4.86 | 4.79 | 4.79 | 4.78 | 4.78 |
| Total Assets ⓘ | 22.23 | 21.59 | 21.60 | 21.35 | 21.01 | 17.99 | 17.88 | 12.33 | 12.23 | 12.17 |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 0.18 | 0.05 | -0.12 | -0.07 | 0 | 0.02 | -0.13 | 0.27 | -0.10 | -0.07 |
| PBT ⓘ | -0.86 | -0.57 | -0.07 | -0.30 | -0.30 | -1.01 | -0.39 | -0.30 | -0.18 | -0.12 |
| Adjustment ⓘ | 0.76 | 0.56 | 0.39 | 0.43 | 0.34 | 0.95 | 0.07 | 0.07 | 0.07 | 0.07 |
| Changes in Working Capital ⓘ | 0.29 | 0.07 | -0.44 | -0.2 | -0.05 | 0.08 | 0.19 | 0.49 | 0.01 | -0.02 |
| Tax Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow From Investing Activity ⓘ | -0.17 | 0 | 0.01 | 0.03 | 0 | 1.97 | -0.01 | 0 | 0 | 0 |
| Capex | 0 | 0 | 0.01 | 0 | 0 | 1.97 | -0.01 | 0 | 0 | 0 |
| Net Investments | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | -0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow From Financing Activityⓘ | -0.02 | -0.05 | 0.11 | 0.05 | 0 | -1.99 | 0.15 | -0.25 | 0.07 | 0.07 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 0.11 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | -0.02 | -0.05 | 0 | 0 | 0 | -1.99 | 0.15 | -0.25 | 0.07 | 0.07 |
| Net Cash Flow ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.03 | -0.02 | 0 |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | -6.26 | -4.39 | -0.36 | -2.12 | -2.41 | -8.6 | -3.5 | -2.93 | -1.8 | -1.22 |
| ROCE (%) | -3.68 | -2.56 | -0.06 | -1.43 | -1.57 | -5.38 | -2.07 | -2.01 | -1.5 | -0.98 |
| Asset Turnover Ratio | 0.04 | 0.02 | 0.03 | 0.02 | 0.01 | 0 | 0.01 | 0.03 | 0.04 | 0.05 |
| PAT to CFO Conversion(x) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Working Capital Days |
| Receivable Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 13 | 18 | 5 | 7 | 11 | 0 | 1 | 1 | 1 | 2 |
| Payable Days | 5 | 39 | 17 | 6 | 17 | 20 | 5 | 0 | 0 | 0 |
Dolphin Medical Services Ltd. is an organization promoted by the doctors of the region. The chief promoters are Dr. M S S Koteswara Rao, an eminent physician and former Minister for health in Andhra Pradesh and Dr. G V Mohan Prasad, a radiologist cum ENT specialist who is also the Managing Director of the company. Dolphin was founded with a lofty ideal of providing quality medical services to improve the quality of life of the people through better health, in the last decade of the the 20th century by renowned medical technologists.
The company provides comprehensive Diagnostic Services since 1994, with a range of tests covering radiology and imaging, biochemistry, pathology and microbiology, etc., to the people of the coastal region of Andhra Pradesh.
The maiden venture of the group started at Visakhapatnam providing medical diagnostic services ranging from simple laboratory test to the complex whole body CT scanning under one roof thus saving the time and energy of the patients and assuring them accurate and prompt services.
Later, the group extended its activities to Vijayawada, a commercial, educational and medical centre of the coastal Andhra Pradesh and established a diagnostic centre with the most sophisticated and state-of-the-art equipment.The group turned a new leaf in providing diagnostic services in the medical field. Subsequently, the group opened an eye-care laser centre, the first of its kind unit in the entire coastal Andhra Pradesh. The eye-care laser centre is equipped with the ultra-modern laser equipment to provide readily available and highly reliable services to the patients of ophthalmic problems.
The company was able to withstand the tough competition in the market and still enhance the profitability of the company. The present status of the company is that the it is debt free and is profit making for the past three years with the profits increasing year after year. In addition it has also the eye care division called the “Dolphin Nethralaya†which is a comprehensive eye care and laser and research centre.The company has also ventured in to IT and biotechnology and Herbal sectors but attained only limited progress in these sectors due to some inherent constraints.
Services offered by the company:
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
